The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - BMJ
 
Consulting or Advisory Role - Seagen
Outcomes in minority patients (pt) with aggressive B cell lymphoma (BCL) if optimally managed with equal access to care and nurse navigation (NN).
 
Bei Hu
Consulting or Advisory Role - Bayer; Cellectar; Kite, a Gilead company
Research Funding - BeiGene (Inst); Genentech (Inst)
 
Tommy Chen
No Relationships to Disclose
 
Danielle Boselli
No Relationships to Disclose
 
Lisa Pye
No Relationships to Disclose
 
Rupali Bose
No Relationships to Disclose
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group
 
James Thomas Symanowski
Consulting or Advisory Role - Boston Biomedical; CARsgen Therapeutics; Endocyte (Inst); Five Prime Therapeutics; Immatics; Lilly
 
Kris Blackley
No Relationships to Disclose
 
Tamara Kay Moyo
No Relationships to Disclose
 
Ryan Jacobs
Consulting or Advisory Role - Abbvie; AstraZeneca; Pharmacyclics; Seagen; Verastem
Speakers' Bureau - Abbvie; AstraZeneca; Genentech; Janssen; Pharmacyclics; Sanofi
Research Funding - Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Steven Park
No Relationships to Disclose
 
Amy Soni
No Relationships to Disclose
 
Belinda Avalos
No Relationships to Disclose
 
Edward Alan Copelan
No Relationships to Disclose
 
Nilanjan Ghosh
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Janssen Oncology; Kite/Gilead; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)